keyboard_arrow_up

Austria Pharmaceuticals and Healthcare Market Report Q2 2015

The Austrian pharmaceutical and healthcare sectors are well developed and stable, offering some of the most attractive opportunities in the region. Our updated forecasts indicate a continuing moderate rebound in both pharmaceutical and healthcare expenditure in 2015 in local currency terms as opposed to weak numbers achieved in 2013 This is encouraging given the fact that the market will continue to be affected by the drug pricing restrictions and public spending cuts.

Headline Expenditure Projections:

  • Pharmaceuticals: EUR4.71bn (USD6.31bn) in 2014 to EUR4.92bn (USD5.41bn) in 2015; +4.4% in local currency terms and -14.3% in US dollar terms.
  • Healthcare: EUR36.86bn (USD49.40bn) in 2014 to EUR38.21bn (USD42.03bn) in 2015; +3.7% in local currency terms and -14.9% in US dollar terms.

Purchase a Copy of this Report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=308960 .

Table of Contents

Industry View 7
SWOT 9
Political 11
Economic 12
Industry Forecast 13
Pharmaceutical Market Forecast . 13
Table: Pharmaceutical Sales, Historical Data And Forecasts (Austria 2011-2019) 14
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Austria 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Austria 2011-2019) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Austria 2011-2019) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Austria 2011-2019) 20
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Austria 2011-2019) 22
Generic Drug Market Forecast 23
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Austria 2011-2019) 25
OTC Medicine Market Forecast 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Austria 2011-2019) 27
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Austria 2013-2019) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Austria 2013-2019) 29
Key Risks To BMI's Forecast 29
Macroeconomic Forecasts 30
Economic Analysis 30
Table: Economic Activity (Austria 2009-2018) 34
Industry Risk Reward Ratings 35
Western Europe Risk/Reward Index 35
Austria Risk/Reward Ratings 40
Rewards 40
Risks 40
Market Overview 42
Industry Trends And Developments 44
Epidemiology 44
Healthcare Sector 45
Clinical Trials 47
Regulatory Development 48
Intellectual Property Issues 50
Competitive Landscape 53
Research-Based Industry 53
Pharmaceutical Distribution 55
Table: Members Of ARGE Pharmazeutika, 2011 56
Pharmaceutical Retail 58
Table: Pharmacy Outlets by Type, 2005-2009 59
Table: Pharmacy Outlets by State, 2005-2009 59
Demographic Forecast 60
Table: Population Headline Indicators (Austria 1990-2025) 61
Table: Key Population Ratios (Austria 1990-2025) 61
Table: Urban/Rural Population & Life Expectancy (Austria 1990-2025) 62
Table: Population By Age Group (Austria 1990-2025) 62
Table: Population By Age Group % (Austria 1990-2025) 63
Glossary 65
Methodology 67
Pharmaceutical Expenditure Forecast Model 67
Healthcare Expenditure Forecast Model 67
Notes On Methodology 68
Risk/Reward Index Methodology 69
Index Overview 70
Table: Pharmaceutical Risk/Reward Index Indicators 70
Indicator Weightings 71

List of Tables

Table: Pharmaceutical Sales, Historical Data And Forecasts (Austria 2011-2019)
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Austria 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Austria 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Austria 2011-2019)
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Austria 2011-2019)
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Austria 2011-2019)
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Austria 2011-2019)
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Austria 2011-2019)
Table: Pharmaceutical Trade Data And Forecasts (Austria 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Austria 2013-2019)
Table: Economic Activity (Austria 2009-2018)
Table: Members Of ARGE Pharmazeutika, 2011
Table: Pharmacy Outlets by Type, 2005-2009
Table: Pharmacy Outlets by State, 2005-2009
Table: Population Headline Indicators (Austria 1990-2025)
Table: Key Population Ratios (Austria 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Austria 1990-2025)
Table: Population By Age Group (Austria 1990-2025)
Table: Population By Age Group % (Austria 1990-2025)
Table: Pharmaceutical Risk/Reward Index Indicators

Complete Report is Available @ http://www.rnrmarketresearch.com/austria-pharmaceuticals-and-healthcare-report-q2-2015-market-report.html .